What Is The Forecast Valuation Of The Global Hospital-Acquired Infection Control Market Projected To Reach $44.06 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Hospital-Acquired Infection Control Market Size?
The consistent increase in the size of the hospital-acquired infection control market has been observed in the past few years. It is projected to escalate from $34.59 billion in 2024 to reach $35.75 billion in 2025, with a compound annual growth rate (CAGR) of 3.4%. Factors such as rising antibiotic resistance, heightened awareness, strict regulations, the global spread of infectious diseases and initiatives aimed at patient safety have contributed to the growth seen in the historic period.
In the coming years, strong expansion is predicted for the market size of hospital-acquired infection control, which is projected to reach $44.06 billion in 2029 with a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period can be accredited to the emergence of multidrug-resistant pathogens, pandemic readiness, heightened surveillance and monitoring, antimicrobial stewardship initiatives, and global collaboration. Key trends seen during the forecast period include the adoption of real-time location systems (RTLS), the inclusion of artificial intelligence (AI) for surveillance, a shift towards single-use and disposable devices, a focus on staff training and education, and an increase in the use of disinfection technologies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp
Which Factors Are Steering Growth In The Hospital-Acquired Infection Control Market?
The escalation in COVID-19 cases globally is anticipated to fuel the expansion of the hospital-acquired infection control market. COVID-19 is a viral contagion triggered by the SARS-CoV-2 virus. The pandemic has led to a surge in demand for hospital-acquired infection control products and services, prioritizing personal hygiene and increasing the manufacture of infection control medical supplies. For example, the World Health Organization, a specialized agency of the United Nations headquartered in Switzerland, reported that by 8th August 2022, the total number of COVID-19 cases globally had risen to 581.6 million. Thus, the rise in COVID-19 infections is catalyzing the growth of the hospital-acquired infection control market.
How Is The Hospital-Acquired Infection Control Market Organized By Different Segments?
The hospital-acquired infection controlmarket covered in this report is segmented –
1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
8) By Other Products: Cleaning Equipment; Air Purification Systems
What Key Trends Are Driving Growth In The Hospital-Acquired Infection Control Market?
Key players in the hospital-acquired infection control market are striving to create new tech solutions such as an AI system that can recognize sepsis at an early stage, therefore improving patient results by enabling swifter diagnosis and treatment. This AI system for early detection of sepsis utilizes cutting-edge technology with artificial intelligence and machine learning algorithms to identify preliminary indications of sepsis in patients. For example, in April 2024, Prenosis Inc., a healthcare establishment based in the US, gained FDA marketing consent for the Sepsis ImmunoScore, the inaugural AI-powered system intended to foresee sepsis, a severe condition that could result in serious complications. This revolutionary device improves early sepsis detection through real-time data interpretation, empowering healthcare workers to respond more promptly and efficiently. The purpose of integrating AI is to aid medical personnel in decision-making rather than to replace them, ultimately enhancing patient results and curbing healthcare expenditure.
Who Are The Most Influential Companies In The Hospital-Acquired Infection Control Market?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
Access The Complete Report Here:
Which Region Dominates The Hospital-Acquired Infection Control Market Today?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp
Browse Through More Reports Similar to the Global Hospital-Acquired Infection Control Market 2025, By The Business Research Company
Advanced Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-analytics-global-market-report
Procurement Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/procurement-analytics-global-market-report
Healthcare Predictive Analytics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
